Company Encyclopedia
View More
name
Biodexa Pharmaceuticals
BDRX.US
Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes. The company is also developing MTX110, which is currently in Phase I studies for the treatment of diffuse intrinsic recurrent glioblastoma, diffuse midline glioma, and medulloblastoma. In addition, the company offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release therapeutics; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents.
1.902 T
BDRX.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Shares Still Up This Week

    European equities traded as American Depositary Receipts in the US fell 1% on Friday, despite being up 1.3% for the week. Notable gainers included Telefonica, Ascendis Pharma, Equinor, and Novo Nordisk. Decliners included Cellectis, DBV Technologies, Nokia, and EDAP TMS. In the UK and Ireland, Akari Therapeutics and Autolus Therapeutics led gains, while Biodexa Pharmaceuticals and British American Tobacco saw significant declines.

    fidelity·
    US
    AKTX
    -5.02%
    US
    DBVT
    -5.43%
    US
    ASND
    +4.88%
    fidelity·
    US
    AKTX
    -5.02%
    US
    DBVT
    -5.43%
    US
    ASND
    +4.88%

    U.S. Stock Movement Update: Agape ATP surges 87%, Oriental Culture plummets 79%, multiple stocks show significant movement

    Market Overview of US Stocks in the Last Hour The US stock market has shown a significant sector rotation in the past hour, with technology and pharmaceutical stocks performing particularly well. Small-cap stocks and thematic stocks have experienced large fluctuations, with noticeable capital inflows. Market sentiment is relatively active, with short-term enthusiasm rising, and some individual stocks have shown significant price movements. The stock with the largest abnormal movement in the last hour is Agape ATP, which surged 87.35%, with trading volume significantly increasing and short-term capital inflows evident, leading to heightened market sentiment. Strong stocks include: 1. SMX Security Matters: up 67.70%, with a 10-day increase of 1113.76%, driven significantly by short-term capital. 2. Grande: up 59.08%, with a 5-day increase of 58.77%, gaining market attention. 3. HeartBeam: up 52.91%, with a 6-month increase of 51.28%, showing clear capital inflows. 4. Velo3D: up 38.26%, with increased trading volume and active short-term capital. 5. Mawson Infrastructure: up 37.54%, with increased trading volume and positive market sentiment. 6. Treasure Gbl: up 26.62%, with increased trading volume driven by short-term capital. 7. CapsoVision: up 25.59%, with increased trading volume and heightened market attention. 8. Nextdoor: up 25.34%, reaching a new 60-day high, with noticeable capital inflows

    Tracking Unusual Activity·
    US
    BDRX
    -24.60%
    Tracking Unusual Activity·
    US
    BDRX
    -24.60%

    Pre-market hot trades in US stocks: Ashford Hospitality Trust pre-market down 14.29%; Biodexa Pharmaceuticals pre-market down 11.46%

    Ashford Hospitality Trust pre-market down 14.29%; Biodexa Pharmaceuticals pre-market down 11.46%; Agape ATP pre-market up 159.71%; Galaxy Payroll pre-market up 36.28%; Boqi Pet pre-market up 23.00%

    Tracking Unusual Activity·
    US
    AHT
    -7.88%
    US
    BDRX
    -24.60%
    Tracking Unusual Activity·
    US
    AHT
    -7.88%
    US
    BDRX
    -24.60%

    U.S. stock night market volatility: Biodexa Pharmaceuticals fell 4.32% in after-hours trading, with active trading causing fluctuations

    Biodexa Pharmaceuticals fell 4.32% in after-hours trading; Recursion Pharmaceuticals fell 1.68% in after-hours trading, with a transaction volume of USD 294,600; Moderna fell 0.55% in after-hours trading, with a transaction volume of USD 77,300; CRISPR Therapeutics fell 0.94% in after-hours trading, with a transaction volume of USD 41,700

    Tracking Unusual Activity·
    US
    BDRX
    -24.60%
    Tracking Unusual Activity·
    US
    BDRX
    -24.60%

    U.S. Stock Market Movement Quick Report: Horizon Space up 62%, Aimei Health down 40%, tech stocks active

    Overview of the US Stock Market In the past hour, the US stock market has shown a significant sector rotation phenomenon. Stocks in the technology and pharmaceutical sectors have performed particularly well, with noticeable capital inflows and a sustained increase in short-term enthusiasm. Small-cap stocks and thematic stocks have experienced large fluctuations, with active market sentiment and an apparent increase in investors' risk appetite. Overall, there is a clear divergence in market strength, with a rapid switching rhythm of funds between different sectors. The stock with the largest movement, Horizon Space Acquisition I, leads the market with a 62.17% increase, attracting significant attention from short-term funds. The strong performance of this stock seems to be driven by optimistic expectations regarding its future potential, with a faster pace of capital inflow and significant volatility. Strong stocks: 1. Biodexa Pharmaceuticals: up 26.78%, the active performance of the pharmaceutical sector has driven the stock's rise, with noticeable capital inflows. 2. Polestar Automotive UK PLC - CW 27: up 18.02%, the overall recovery of the automotive sector has provided support, with active participation from short-term funds. 3. Destiny Tech100: up 14.00%, the strong performance of the technology sector has provided a favorable market environment, enhancing investor confidence. 4. Rising Dragon Acquisition: up 12.17%, with optimistic expectations for its future development, the pace of capital inflow has accelerated

    Tracking Unusual Activity·
    US
    BDRX
    -24.60%
    Tracking Unusual Activity·
    US
    BDRX
    -24.60%
    © 2025 Longbridge｜Disclaimer